The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog

Am J Physiol Endocrinol Metab. 2000 Aug;279(2):E463-73. doi: 10.1152/ajpendo.2000.279.2.E463.

Abstract

The role of alpha- and beta-adrenergic receptor subtypes in mediating the actions of catecholamines on hepatic glucose production (HGP) was determined in sixteen 18-h-fasted conscious dogs maintained on a pancreatic clamp with basal insulin and glucagon. The experiment consisted of a 100-min equilibration, a 40-min basal, and two 90-min test periods in groups 1 and 2, plus a 60-min third test period in groups 3 and 4. In group 1 [alpha-blockade with norepinephrine (alpha-blo+NE)], phentolamine (2 microg x kg(-1) x min(-1)) was infused portally during both test periods, and NE (50 ng x kg(-1) x min(-1)) was infused portally at the start of test period 2. In group 2, beta-blockade with epinephrine (beta-blo+EPI), propranolol (1 microg x kg(-1) x min(-1)) was infused portally during both test periods, and EPI (8 ng x kg(-1) x min(-1)) was infused portally during test period 2. In group 3 (alpha(1)-blo+NE), prazosin (4 microg x kg(-1) x min(-1)) was infused portally during all test periods, and NE (50 and 100 ng x kg(-1) x min(-1)) was infused portally during test periods 2 and 3, respectively. In group 4 (beta(2)-blo+EPI), butoxamine (40 microg x kg(-1) x min(-1)) was infused portally during all test periods, and EPI (8 and 40 ng x kg(-1) x min(-1)) was infused portally during test periods 2 and 3, respectively. In the presence of alpha- or alpha(1)-adrenergic blockade, a selective rise in hepatic sinusoidal NE failed to increase net hepatic glucose output (NHGO). In a previous study, the same rate of portal NE infusion had increased NHGO by 1.6 +/- 0.3 mg x kg(-1) x min(-1). In the presence of beta- or beta(2)-adrenergic blockade, the selective rise in hepatic sinusoidal EPI caused by EPI infusion at 8 ng x kg(-1) x min(-1) also failed to increase NHGO. In a previous study, the same rate of EPI infusion had increased NHGO by 1.6 +/- 0.4 mg x kg(-1) x min(-1). In conclusion, in the conscious dog, the direct effects of NE and EPI on HGP are predominantly mediated through alpha(1)- and beta(2)-adrenergic receptors, respectively.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3-Hydroxybutyric Acid / blood
  • Adrenergic beta-Antagonists / pharmacology
  • Amino Acids / blood
  • Animals
  • Arteries / physiology
  • Blood Glucose / drug effects
  • Catecholamines / metabolism*
  • Catecholamines / pharmacology
  • Dogs
  • Epinephrine / metabolism
  • Epinephrine / pharmacology
  • Fatty Acids, Nonesterified / blood
  • Female
  • Glucagon / blood
  • Glucose / administration & dosage
  • Glucose / biosynthesis*
  • Glycerol / blood
  • Hydrocortisone / blood
  • Infusions, Intravenous
  • Insulin / blood
  • Lactic Acid / blood
  • Liver / blood supply
  • Liver / drug effects
  • Liver / metabolism*
  • Male
  • Norepinephrine / metabolism
  • Norepinephrine / pharmacology
  • Portal Vein / physiology
  • Receptors, Adrenergic, alpha-1 / metabolism*
  • Receptors, Adrenergic, beta-2 / metabolism*

Substances

  • Adrenergic beta-Antagonists
  • Amino Acids
  • Blood Glucose
  • Catecholamines
  • Fatty Acids, Nonesterified
  • Insulin
  • Receptors, Adrenergic, alpha-1
  • Receptors, Adrenergic, beta-2
  • Lactic Acid
  • Glucagon
  • Glucose
  • Glycerol
  • 3-Hydroxybutyric Acid
  • Hydrocortisone
  • Norepinephrine
  • Epinephrine